Processing

Please wait...

Settings

Settings

Goto Application

1. CN104540822 - Novel crystal form of dabrafenib mesylate and preparation method thereof

Office
China
Application Number 201480002089.3
Application Date 03.07.2014
Publication Number 104540822
Publication Date 22.04.2015
Grant Number 104540822
Grant Date 31.08.2016
Publication Kind B
IPC
C07D 417/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
417Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/196
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
A61K 31/506
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
C07D 417/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
417Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants 杭州普晒医药科技有限公司
Inventors 劳海萍
盛晓霞
盛晓红
Priority Data 2013102837054 08.07.2013 CN
Title
(EN) Novel crystal form of dabrafenib mesylate and preparation method thereof
(ZH) 达拉菲尼甲磺酸盐的晶型及其制备方法
Abstract
(EN) Disclosed are a novel crystal form of Dabrafenib mesylate and preparation method thereof. The novel crystal form of the present invention is more stable in water or an aqueous system, and has greater solubility and dissolution in water, thus having better stability and bioavailability compared with the existing crystal forms.
(ZH) 本发明涉及达拉菲尼甲磺酸盐的新晶型及其制备方法。本发明所述新晶型具有在水或含水体系中更稳定和水中溶解度、溶出量更大的优点,因此相对于现有的晶型,具有更好的稳定性和生物利用度。
Related patent documents